The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
Liver transplantation is a treatment option for nonresectable patients with early-stage HCC, with more significant advantages when Milan criteria are fulfilled. An immunosuppressive regimen is required to reduce the risk of graft rejection after transplantation, and CNIs represent the drugs of choic...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2023-06-01
|
| Colección: | Current Oncology |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/1718-7729/30/6/421 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|